Loading…
Legislative Progress
Introduced
December 12, 2019
Latest Action
January 28, 2020
Primary Sponsor
Blaine LuetkemeyerRepublican(MO)
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
85pct
47d open
vs 9,062 other HR bills in the 116th — cohort avg 39d
Stopping Illicit Trafficking Act of 2019 or the SIFT Act of 2019 This bill adds five fentanyl analogues and the entire category of fentanyl-related substances to schedule I of the Controlled Substances Act. A schedule I controlled substance is a drug, substance, or chemical that has a high potential for abuse; has no currently accepted medical value; and is subject to regulatory controls and administrative, civil, and criminal penalties under the Controlled Substances Act. The bill also creates a process to remove from schedule I certain fentanyl-related substances that do not have a high potential for abuse.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (1)
2020 · third_quarter · Health Issues
H.R.7614, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2021, Provisions relating to NIH, substance use research Barriers to research resulting from DEA scheduling, Drug research related issues S. 2032, Cannabidiol & Marijuana Research Expansion Act, Drug abuse research related issues H.R.3797, Medical Marijuana Research Act of 2019, Drug abuse research related issues Monitor Drug abuse research related issues, as follows: Stop the Importation and Trafficking of Synthetic Analogues (SITSA) S.3148, Stopping Overdoses of Fentanyl Analogues Act H.R.2935/S.1622, Stopping Overdoses of Fentanyl Analogues Act S.2701, Federal Initiative to Guarantee Health by Targeting Fentanyl Act H.R.5421, Stopping Illicit Trafficking Act of 2019 Public Law 116-114, Temporary Reauthorization and Study of the Emergency Scheduling of Fentanyl Analogues Act Public Law 115-334, Agriculture Improvement Act of 2018, Hemp related provision Non Human Primates and Biomedical research H.R.601, Medical Cannabis Research Act Coronavirus, Healthcare research related issues
Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.
Referred to the Subcommittee on Health.
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Introduced in House
Congress.gov source codes: 1000, Intro-H
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
2020 · second_quarter · Health Issues
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2021, Provisions relating to NIH, substance use research Drug abuse research related issues, as follows: Stop the Importation and Trafficking of Synthetic Analogues (SITSA) Barriers to research resulting from DEA scheduling S.3148, Stopping Overdoses of Fentanyl Analogues Act H.R.2935/S.1622, Stopping Overdoses of Fentanyl Analogues Act S.2701, Federal Initiative to Guarantee Health by Targeting Fentanyl Act H.R.5421, Stopping Illicit Trafficking Act of 2019 Public Law 116-114, Temporary Reauthorization and Study of the Emergency Scheduling of Fentanyl Analogues Act Monitor Drug abuse research related issues, as follows: S. 2032, Cannabidiol & Marijuana Research Expansion Act H.R.3797, Medical Marijuana Research Act of 2019 Public Law 115-334, Agriculture Improvement Act of 2018, Hemp related provision Non Human Primates and Biomedical research H.R.601, Medical Cannabis Research Act Coronavirus, Healthcare research related issues
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
2020 · first_quarter · Health Issues
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2021, Provisions relating to NIH, substance use research Drug abuse research related issues, as follows: S. 2032, Cannabidiol & Marijuana Research Expansion Act Stop the Importation and Trafficking of Synthetic Analogues (SITSA) H.R.3797, Medical Marijuana Research Act of 2019 Public Law 115-334, Agriculture Improvement Act of 2018, Hemp related provision Barriers to research resulting from DEA scheduling Non Human Primates and Biomedical research H.R.601, Medical Cannabis Research Act H.R.2935/S.1622, Stopping Overdoses of Fentanyl Analogues Act S.2701, Federal Initiative to Guarantee Health by Targeting Fentanyl Act S.3148, Stopping Overdoses of Fentanyl Analogues Act Public Law 116-114, Temporary Reauthorization and Study of the Emergency Scheduling of Fentanyl Analogues Act H.R.5421, Stopping Illicit Trafficking Act of 2019 Monitor Coronavirus, Healthcare related issues
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
| Republican |
| NY |
| Emanuel Cleaver | Democratic | MO |
| Eric A. "Rick" Crawford | Republican | AR |
| Glenn Grothman | Republican | WI |
| James Comer | Republican | KY |
| James R. Baird | Republican | IN |
| Jason Smith | Republican | MO |
| Rick W. Allen | Republican | GA |
| Rodney Davis | Republican | IL |
| Sam Graves | Republican | MO |
| Ted S. Yoho | Republican | FL |
| Troy Balderson | Republican | OH |
| Vicky Hartzler | Republican | MO |
| Wm. Lacy Clay | Democratic | MO |
| HR 5771 |
116th |
| Related bill |
| HR 2935 | 116th | Related bill |